Requirements for Successful Completion: Complete the learning activity in its entirety and complete the online CNE evaluation. Faculty, Planners and Authors Conflict of Interest Disclosure: The author(s), editor, editorial board, content reviewers, and education director reported no actual or potential conflict of interest in relation to this continuing nursing education article.
Commercial Support and Sponsorship: No commercial support or sponsorship declared.
Accreditation Statement: This educational activity is provided by the Society of Urologic Nurses and Associates (SUNA).
The Society of Urologic Nurses and Associates (SUNA) is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
SUNA is a provider approved by the California Board of Registered Nursing, Provider Number CEP 5556.
This article was reviewed and formatted for contact hour credit by Michele Boyd, MSN, RN, NPD-BC, SUNA Education Director. Learning Outcome: After completing this education activity, the learner will be able to discuss how prophylactic use of an alpha-2 adrenergic receptor agonist may attenuate CRBD, a postoperative complication characterized by a burning sensation, bladder discomfort, and the urge to urinate.